Rapamycin induces autophagy and exacerbates metabolism associated complications in a mouse model of type 1 diabetes

Indian Journal of Experimental Biology

Volumn 48, Issue 1, 2010, Pages 31-38

  Zhou, Zhengyu ^a   Wu, Shuyan ^a   Li, Xinyin ^a   Xue, Zhimou ^a   Tong, Jian ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Autophagy; Mouse model; Rapamycin; Type 1 diabetes mellitus

Indexed keywords

MAMMALIA; MUS;

CASP3 PROTEIN, MOUSE; CASPASE 3; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ANIMAL; ARTICLE; AUTOPHAGY; C57BL MOUSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; AUTOPHAGY; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; SIROLIMUS;

EID: 77951888745     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Diabetes Fact Sheet, WHO, November 2008, http://www.who.int/mediacentre/factsheets/fs312/en/
2. Tanemura M, Saga A, Kawamoto K, Machida T, Deguchi T, Nishida T, Sawa Y, Doki Y, Mori M & Ito T, Rapamycin induces autophagy in islets: revelance in islet transplantation, Transplantation Proceedings, 41 (2009) 334.
3. Chi Kwan Tsang, Haiyan Qi, Leroy F. Liu & X.F. Steven Zheng, Targeting mammalian target of rapamycin (mTOR) for health and diseases, Drug Discovery Today, 12 (2007)112.
4. Abraham RT & Wiederrecht GJ, Immunopharmacology of rapamycin, Annu Rev Immunol 14 (1996) 483.
5. Bussiere CT, Lakey JR, Shapiro AM & Korbutt GS, The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells, Diabetologia, 49 (2006) 2341.
6. Marcelli TS, Hubert T, Moerman E, Gmyr V, Kerr CJ, Nunes B, Dherbomez M, Vandewalle B, Pattou F & Vantyghem MC, In vivo and in vitro effect of sirolimus on insulin secretion, Transplantation, 83 (2007) 532.
7. Leibowitz G,Cerasi E & Ketzinel GM, The role of mTOR in the adaptation and failure of (β-cells in type 2 diabetes, Diabetes Obesity Metabolism, 10 (2008) 157.
8. Fraenkel M, Ketzinel G M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N & Leibowitz G, mTOR inhibition by rapamycin prevents β-cell adaptation to hyperglycemia and exacerbates the metab olic state in type 2 diabetes, Diabetes, 57 (2008) 945.
9. Zhang N, Su D, Qu S, Tse T, Bottino R, Balamurugan AN, Xu J, Bromberg JS & Dong HH, Sirolimus is associated with reduce islet engraftment and impaired (β-cell function, Diabetes, 55 (2006) 2429.
10. Apel A, Zentgraf H, Büchler MW & Herr I, Autophagy-A double-edged sword in oncology, Int J Cancer, 125 (2009) 991.
11. Jung HS & Lee MS, Macroautophagy in homeostasis of pancreatic β-cell, Autophagy, 5 (2009) 241.
12. Marsh BJ, Soden C, Alarcón C, Wicksteed BL, Yaekura K, Costin AJ, Morgan GP & Rhodes CJ, Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine beta-cells,Mol Endocrinol, 21 (2007) 2255.
13. Sooparb S, Price SR, Shaoguang J & Franch HA, Suppression of chaperone-mediated autophagy in the renalcortex during acute diabetes mellitus, Kidney Int, 65 (2004) 2135.
14. Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A & Brumell JH, Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy, Diabetes, 56 (2007) 930.
15. Motyl K & McCabe LR, Streptozotocin, Type I diabetes severity and bone, Biol Proced Online, 2009; Mar 6. [Epub ahead of print]
16. Kang SI, Jin YJ, Ko HC, Choi SY, Hwang JH, Whang I, Kim MH, Shin HS, Jeong HB & Kim SJ, Petalonia improves glucose homeostasis in streptozotocin-induced diabetic mice, Biochem Biophys Res Commun, 373 (2008) 265.
17. Ohly P, Wang Z, Abel J & Gleichmann H, Zincsulphate induced metallothionein in pancreatic islets and protected against the diabetogenic toxin streptozotocin, Talanta, 46 (1998) 355.
18. Ku CH, White KE, Dei Cas A, Hayward A, Webster Z, Bilous R, Marshall S, Viberti G &, Gnudi L, Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice, Diabetes, 57 (2008) 2824.
19. Mori H, Inoki K, Masutani K, Wakabayashi Y, Komai K, Nakagawa R, Guan KL & Yoshimura A, The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential, Biochem Biophys Res Commun, 384 (2009) 471.
20. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J & Lowe SW, Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy, Nature, 428 (2004) 332.
21. Kaino Y, Hirai H, Ito T & Kida K, Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice, Diabetes Res Clin Pract, 34 (1996) 7.
22. Meijer AJ & Codogno P, Macroautophagy-Protector in the diabetes drama? Autophagy, 3 (2007) 523.
23. Fujitani Y, Kawamori R & Watada H, The role of autophagy in pancreatic beta-cell and diabetes, Autophagy, 5 (2009) 280.
24. Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, Azuma K, Hirose T, Tanaka K, Kominami E, Kawamori R, Fujitani Y & Watada H, Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet, Cell Metab, 8 (2008) 325.
25. Masini M, Bugliani M, Lupi R, del Guerra S, Boggi U, Filipponi F, Marselli L, Masiello P & Marchetti P, Autophagy in human type 2 diabetes pancreatic beta cells, Diabetologia, 52 (2009) 1083.
26. Meijer AJ & Codogno P, Autophagy: a sweet process in diabetes, Cell Metab, 8 (2008) 275.
27. Codogno P & Meijer AJ, Autophagy and signaling: their role in cell survival and cell death, Cell Death Differ, 12 (2005) 1509.
28. Kroemer G & Levine B, Autophagic cell death: the story of a misnomer, Nat Rev Mol Cell Biol, 9 (2008) 1004.
29. Maiuri MC, Zalckvar E, Kimchi A & Kroemer G, Self-eating and self-killing: crosstalk between autophagy and apoptosis, Nat Rev Mol Cell Biol, 8 (2007) 741.